| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 50.69▲ | 50.56▲ | 50.56▲ | 50.84▼ | 52.42▼ |
| MA10 | 50.60▲ | 50.64▲ | 50.67▲ | 51.33▼ | 50.58▲ |
| MA20 | 50.67▲ | 50.79▼ | 50.94▼ | 52.25▼ | 46.20▲ |
| MA50 | 51.28▼ | 51.88▼ | 52.11▼ | 49.93▲ | 41.92▲ |
| MA100 | 52.23▼ | 51.83▼ | 50.88▼ | 45.45▲ | 42.87▲ |
| MA200 | 49.84▲ | 47.21▲ | 45.76▲ | 41.77▲ | 41.05▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.061▲ | 0.052▲ | 0.026▲ | -0.423▼ | 0.509▲ |
| RSI | 45.698▼ | 42.501▼ | 41.425▼ | 47.122▼ | 65.098▲ |
| STOCH | 56.286 | 25.191 | 27.145 | 18.054▼ | 80.032▲ |
| WILL %R | -36.905 | -33.696 | -78.966▼ | -81.697▼ | -26.436 |
| CCI | 29.140 | 48.066 | -16.186 | -91.553 | 42.402 |
|
Monday, December 22, 2025 05:43 AM
Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/12/25 | 50.37 | 50.76 | 50.37 | 50.7261 | 7,606 |
| 23/12/25 | 50.35 | 50.595 | 50.35 | 50.4745 | 16,274 |
| 22/12/25 | 50.32 | 50.84 | 50.08 | 50.7277 | 55,546 |
| 19/12/25 | 50.74 | 51.7734 | 50.74 | 51.687 | 7,668 |
| 18/12/25 | 50.8255 | 51.02 | 50.55 | 50.5642 | 11,434 |
| 17/12/25 | 51.83 | 51.83 | 50.96 | 50.9757 | 7,989 |
| 16/12/25 | 51.69 | 51.77 | 51.155 | 51.5788 | 13,294 |
| 15/12/25 | 52.5427 | 52.5427 | 51.89 | 51.938 | 5,454 |
| 12/12/25 | 52.55 | 52.6799 | 52.16 | 52.3591 | 3,753 |
| 11/12/25 | 52.29 | 52.62 | 52.09 | 52.2294 | 14,235 |
|
|
||||
|
|
||||
|
|